Is Citius Oncology, Inc. technically bullish or bearish?

As of 1 October 2023, the technical stance for Citius Oncology, Inc. is mixed but leans mildly bearish overall. The weekly MACD is mildly bearish, while the monthly MACD shows a mildly bullish signal. Bollinger Bands indicate a bearish trend for both weekly and monthly periods. Daily moving averages are mildly bullish, suggesting some short-term strength. The KST is mildly bullish on a weekly basis, but there are no clear signals from the RSI or Dow Theory.
In terms of performance, the stock has returned 52.17% year-to-date, significantly outperforming the S&P 500's 12.22% return, but it has underperformed over the past week with a -7.41% return compared to the S&P 500's 1.05%.